Hui-Na Wang Selected Research

Hui-Na Wang Research Topics

4	Anaphylaxis (Anaphylactic Shock) 03/2022 - 07/2020
4	Inflammation (Inflammations) 03/2022 - 01/2021
3	Hypersensitivity (Allergy) 03/2022 - 07/2020
2	Leukemia 03/2022 - 02/2022
2	Adenocarcinoma of Lung 01/2022 - 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Rubella (German Measles) 01/2018

4	OvalbuminIBA 03/2022 - 07/2020
4	Immunoglobulin E (IgE)IBA 03/2022 - 01/2021
2	Human Serum Albumin FDA LinkGeneric 03/2022 - 02/2022
2	AntibodiesIBA 03/2022 - 02/2022
2	Immunoglobulins (Immunoglobulin)IBA 03/2022 - 02/2022
2	Coloring Agents (Dyes)IBA 03/2022 - 02/2022
2	pralsetinibIBA 01/2022 - 01/2022
1	Histamine (Histamine Dihydrochloride)FDA Link 03/2022
1	AntigensIBA 03/2022
1	Flavoring AgentsIBA 03/2022
1	HymecromoneIBA 02/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	3- (5- (4- (cyclopentyloxy)- 2- hydroxybenzoyl)- 2- ((3- hydroxy- 1,2- benzisoxazol- 6- yl)methoxy)phenyl)propionic acidIBA 01/2021
1	OxazoloneIBA 01/2021
1	Pimozide (Orap)FDA Link 07/2020
1	ChromatinIBA 01/2018